IRIS UniCatt

Santoro, Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.548
AS - Asia 3.248
EU - Europa 2.064
SA - Sud America 731
AF - Africa 103
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.401
SG - Singapore 1.451
IT - Italia 626
BR - Brasile 585
CN - Cina 552
VN - Vietnam 408
SE - Svezia 371
FR - Francia 221
DE - Germania 206
IN - India 166
BD - Bangladesh 135
HK - Hong Kong 126
IE - Irlanda 123
FI - Finlandia 120
GB - Regno Unito 101
ID - Indonesia 94
JP - Giappone 91
CA - Canada 69
RU - Federazione Russa 65
NL - Olanda 55
MX - Messico 52
AR - Argentina 48
KR - Corea 33
IQ - Iraq 31
EC - Ecuador 28
TR - Turchia 28
CI - Costa d'Avorio 27
AT - Austria 24
PL - Polonia 24
ES - Italia 23
UA - Ucraina 23
ZA - Sudafrica 23
PK - Pakistan 20
CO - Colombia 19
VE - Venezuela 15
SA - Arabia Saudita 13
EG - Egitto 12
LT - Lituania 12
UZ - Uzbekistan 12
CL - Cile 11
IR - Iran 11
PY - Paraguay 11
RO - Romania 11
BE - Belgio 10
CH - Svizzera 10
JO - Giordania 10
PH - Filippine 10
KE - Kenya 9
MA - Marocco 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
KZ - Kazakistan 6
PT - Portogallo 6
TW - Taiwan 5
DZ - Algeria 4
HN - Honduras 4
IL - Israele 4
JM - Giamaica 4
LV - Lettonia 4
NP - Nepal 4
PE - Perù 4
AL - Albania 3
AU - Australia 3
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
LB - Libano 3
PA - Panama 3
TH - Thailandia 3
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GH - Ghana 2
GR - Grecia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
GD - Grenada 1
Totale 9.685
Salva come PNG Salva come JPEG
Città #
Singapore 832
Chandler 460
Ashburn 392
San Jose 382
Beijing 153
Ho Chi Minh City 153
Rome 153
Dallas 146
New York 133
Los Angeles 132
Dublin 118
Hong Kong 109
Hanoi 87
Hyderabad 87
The Dalles 87
Hefei 86
Lauterbourg 80
Jakarta 79
Milan 78
Council Bluffs 75
Tokyo 74
Helsinki 61
Boston 58
Frankfurt am Main 58
São Paulo 58
Princeton 51
Buffalo 49
Munich 47
San Mateo 41
Moscow 38
Santa Clara 38
Marseille 31
Lappeenranta 30
Wilmington 30
Seoul 29
Abidjan 27
Turku 27
Fairfield 26
Chicago 23
Orem 23
Atlanta 21
Bologna 21
Da Nang 21
Houston 21
Kent 21
St Louis 21
Rio de Janeiro 20
Brooklyn 18
Falkenstein 18
Mexico City 18
Montreal 18
Toronto 18
Warsaw 18
Brasília 17
Paris 17
London 15
Belo Horizonte 14
Denver 14
Düsseldorf 14
Haiphong 14
Redwood City 14
Seattle 14
Chennai 13
Hải Dương 13
Nuremberg 13
Shanghai 13
Stockholm 13
Augusta 12
Guayaquil 12
Johannesburg 12
Palermo 12
Salt Lake City 12
Baghdad 11
Bremen 11
Curitiba 11
Dhaka 11
Nanjing 11
Norwalk 11
Phoenix 11
Vienna 11
Boardman 10
Bogotá 10
Brussels 10
Manchester 10
Tashkent 10
Amman 9
Ann Arbor 9
Biên Hòa 9
Busto Arsizio 9
Charlotte 9
City of London 9
Jacksonville 9
Naaldwijk 9
Poplar 9
Querétaro 9
Washington 9
Cattolica 8
Dearborn 8
Istanbul 8
Kish 8
Totale 5.422
Salva come PNG Salva come JPEG
Nome #
Aberrant non-canonical WNT pathway as key-driver of high-grade serous ovarian cancer development 213
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 198
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 193
Mesonephric-like adenocarcinoma of the endometrium: detailed molecular characterization of the first case showing a morphological continuum from mesonephric-like metaplasia and atypical mesonephric-like hyperplasia to adenocarcinoma 164
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 160
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 155
Radial Scar: a management dilemma 149
The vulvar immunohistochemical panel (Vip) project: Molecular profiles of vulvar squamous cell carcinoma 141
Histopathological evaluation of tumor-infiltrating lymphocytes (TILs) as predictive biomarker for hormone receptors status, proliferative activity and clinical outcome in her-2 positive breast cancer 141
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group 139
Reduction mammoplasty using oxidized regenerated cellulose as a filler in breast conservation surgery 136
The emerging and challenging role of PD-L1 in patients with gynecological cancers: An updating review with clinico-pathological considerations 132
The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features 131
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications 127
Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study 126
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 125
Myofibroblastoma of the breast: two case reports and literature review 125
Neuroendocrine Carcinoma of the Uterine Cervix: A Clinicopathologic and Immunohistochemical Study with Focus on Novel Markers (Sst2-Sst5) 122
Assessing Post-Treatment Pathologic Tumor Response in Female Genital Tract Carcinomas: An Update 122
Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature 122
Morphological and immunohistochemical evaluation in distinguishing post-radiotherapy serous-like endometrial change (PoRSEC) and serous endometrial intraepithelial carcinoma (SEIC) 121
Granular Cell Tumor of the Breast: Clinical Presentation, Pathological Diagnosis and Treatment 121
Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification 120
Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles 118
OncotypeDX (R) predictive nomogram for recurrence score output: A machine learning system based on quantitative immunochemistry analysis-ADAPTED01 118
Diagnostic and Prognostic Role of WT1 Immunohistochemical Expression in Uterine Carcinoma: A Systematic Review and Meta-Analysis across All Endometrial Carcinoma Histotypes 117
Corded and hyalinized endometrioid endometrial carcinoma with high-grade features: a clinicopathological and TCGA-based molecular analysis 116
Ovarian endometrioid carcinoma with a sex cord-like pattern: a morphological, immunohistochemical, and molecular analysis 115
Melanocyte Colonization and Pigmentation of Breast Carcinoma: Description of Two Pathological Cases and Review of Literature 115
SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix 115
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors 115
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience 112
Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors 112
“Clock mapping” prior to excisional surgery in vulvar Paget’s disease: tailoring the surgical plan 112
Prognostic Value of Mandard’s Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer 111
Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer 111
Chemotherapy Response Score (CRS): A comprehensive review of its prognostic and predictive value in High-Grade Serous Carcinoma (HGSC) 110
Prognostic Value of Chemotherapy Response Score (CRS) Assessed on the Adnexa in Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis 108
Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer 108
Retrospective study of histopathological and prognostic characteristics of primary fallopian tube carcinomas: twenty-year experience (SOCRATE) 106
Pilomatrix-like High-Grade Endometrioid Carcinoma of the Ovary: Case Report, Literature Review, and Differential Diagnosis 105
Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease 105
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience 105
An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potential, and Technical Pitfalls 105
Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis 105
Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion 104
The Role of Plasma Cells as a Marker of Chronic Endometritis: A Systematic Review and Meta-Analysis 103
New pathological and clinical insights in endometrial cancer in view of the updated esgo/estro/esp guidelines 101
When a mimicker wears strange faces: Description of an osteogenic melanoma arising within an ovarian teratoma with focus on its late peritoneal relapse 101
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: Our experience 101
Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases 100
Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs 99
Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors 99
Postchemotherapy Endometrioid to Gastrointestinal Histotype Shift in Recurrent Endometrial Carcinoma 99
Peritoneal Carcinomatosis from Yolk Sac Tumor in a Postmenopausal Woman Following Chemotherapy for High-grade Ovarian Serous Carcinoma 98
Low-grade myofibroblastic sarcoma of the breast 98
The Many Faces of Endometriosis-Related Neoplasms in the Same Patient: A Brief Report 98
TCGA molecular subgroups of endometrial carcinoma in ovarian endometrioid carcinoma: A quantitative systematic review 97
Breast Cancer Orbital Metastases: Clinical and Histopathological Characteristics, Imaging Features, and Disease-Related Survival in a Multicentric Retrospective Case Series 97
Evaluation of Beta-Catenin Subcellular Localization and Water Channel Protein AQP1 Expression as Predictive Markers of Chemo-Resistance in Ovarian High-Grade Serous Carcinoma: Comparative Study between Preoperative Peritoneal Biopsies and Surgical Samples 97
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score–matched analysis 96
Endometrial giant cell carcinoma: new insights from a morphological, immunohistochemical, and molecular analysis of three cases 95
Hemangioma of the umbilical cord with associated amnionic inclusion cyst: two uncommon entities occurring simultaneously 94
A new entity in the pathological spectrum of vulvar neoplasms: The first report of a primary endometrioid adenocarcinoma 92
Surgery after upfront chemoradiation in locally advanced squamous cell vulvar cancer: Analysis of postoperative outcomes and survival 91
Incidence, malignancy rates of diagnoses and cyto-histological correlations in the new Italian Reporting System for Thyroid Cytology: An institutional experience. 91
Ultrasound-guided FNA cytology of groin lymph nodes improves the management of squamous cell carcinoma of the vulva: Results from a comparative cytohistological study 91
TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives 89
Acral melanoma of the hallux 89
Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports 89
Ultra-High frequency ultrasound imaging of lymphatic channels correlates with their histological features: A step forward in lymphatic surgery 88
Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer 88
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma 87
The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget's disease 86
Endometrial carcinomas with dyshesive, eosinophilic, and vacuolated (histiocyte-like) tumor cells: a reactive-like phenotype associated with aggressive behavior 86
Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas 85
Ganglioglioma arising in an ovarian teratoma 85
Tamoxifen related Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A case report and literature review of this possible association 85
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication 84
Integrated histological parameters define prognostically relevant groups in atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia 82
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 82
Prognostic significance of atypical mitotic figures in smooth muscle tumors of uncertain malignant potential (STUMP) of the uterus and uterine adnexa 80
Prognostic value of the TCGA molecular classification in uterine carcinosarcoma 78
Neuroendocrine tumors of the submandibular gland: literature review and report of a case 76
Cerebellar metastasis from ovarian carcinoma harboring PIK3CA-activating mutation: A “clear” explanation for an unexpected “vertigo” 76
Predictive factors of sentinel lymph node failed mapping in endometrial carcinoma patients: A systematic review and meta-analysis 69
Breast cancer orbital metastases: Clinical, histopathological features and disease related survival in a retrospective case series 69
The role of cytology in endometrial cancer: Diagnostic and clinical considerations from peritoneal/pelvic washings. Is it still a heated debate? 68
Methylation Profile of X-Chromosome–Related Genes in Male Breast Cancer 60
Accuracy of One-Step Nucleic Acid Amplification in Detecting Lymph Node Metastases in Endometrial Cancer 60
Beyond the WHO 2020 Classification of Female Genital Tumors: Types of Endometrial Cancer: A Pathological and Molecular Focus on Challenging Rare Variants 59
Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma 56
Rethinking certainty: a retrospective study on diagnostic revisions in gynecologic pathology 10
Focal lymphovascular space invasion: Friend or foe? A large retrospective analysis on stage I endometrioid endometrial carcinomas 8
HER2 intratumoral heterogeneity predicts response to neoadjuvant therapy in HER2-positive breast cancer: impact and interplay with HER3 expression 7
Prognostic significance of lymphovascular space invasion extent across molecular classes in early-stage endometrial cancer: A large retrospective analysis 6
Long term outcomes of breast primary sarcomas and malignant phyllodes tumors: 20 years observational analysis of the BEAM∗ study group. (∗the breast European association for mesenchymal tumors) 4
Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancer 4
A Case Report to Reflect on the Origins of MMRd Mesonephric-like Ovarian Adenocarcinoma: Can It Be Defined as a Mϋllerian Neoplasm? 3
Interobserver Agreement in Immunohistochemical Evaluation of Folate Receptor Alpha (FRα) in Ovarian Cancer: A Multicentre Study 3
Totale 9.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022417 16 10 1 41 12 20 13 67 27 18 84 108
2022/20231.184 124 161 93 181 61 156 76 101 133 17 60 21
2023/2024723 25 203 22 32 22 125 41 29 16 45 88 75
2024/20251.806 32 29 128 54 110 75 98 67 209 269 423 312
2025/20265.482 670 197 482 694 806 220 840 286 336 326 286 339
Totale 9.884